PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
19-Aug-2022 Nordic Nanovector to explore strategic options Nordic Nanovector
19-Aug-2022 Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022 Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
19-Aug-2022 Epro to exhibit at prestigious digital health event: the HETT Show 2022 Epro
19-Aug-2022 Douglas GmbH: Release of results for the third quarter and nine months 2021/22 (ending 30 June 2022) on 23 August 2022 Douglas GmbH
19-Aug-2022 PolyPeptide with encouraging progress within custom projects pipeline – however with lower profitability in the first half of 2022 PolyPeptide Group
18-Aug-2022 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
18-Aug-2022 Original-Research: Haemato AG (von First Berlin Equity Research GmbH) Haemato AG
18-Aug-2022 CureVac Announces Financial Results for the Second Quarter and First Half of 2022 and Provides Business Update CureVac
18-Aug-2022 CureVac Starts Phase 1 Clinical Study of Modified, Omicron-Targeting COVID-19 Vaccine Candidate CureVac
18-Aug-2022 Tavneos® (avacopan) recommended by England’s NICE for the treatment of AAV (GPA/MPA) Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
18-Aug-2022 ProBioGen Executes a Master Service Agreement with NextPoint Therapeutics and Starts an Integrated Project from Cell Line Development to GMP Manufacturing ProBioGen
18-Aug-2022 NICE Recommends RINVOQ®▼(upadacitinib) As A Treatment Option For Active Ankylosing Spondylitis (AS) In Adults AbbVie
18-Aug-2022 Sanofi provides update on amcenestrant clinical development program Sanofi
18-Aug-2022 Orgenesis Achieves Revenue of USD 7.2 Million for the Second Quarter of 2022 Orgenesis
18-Aug-2022 Zur Rose Group speeds up path to profitability and plans break-even at EBITDA level in 2023 Zur Rose Group AG
17-Aug-2022 Douglas GmbH: Release of results for the third quarter and nine months 2021/22 (ending 30 June 2022) on 23 August 2022 Douglas GmbH
17-Aug-2022 ProBioGen Executes a Master Service Agreement with NextPoint Therapeutics and Starts an Integrated Project from Cell Line Development to GMP Manufacturing B3C newswire
17-Aug-2022 M1 Kliniken AG announces financials for H1-2022: positive business development despite cooling of general consumer climate M1 Kliniken AG
17-Aug-2022 HAEMATO AG publishes figures for Q2 2022: increase in revenues and EBIT compared to the previous quarter; confirmation of guidance for the full year 2022 HAEMATO AG
17-Aug-2022 Gerresheimer AG: Gerresheimer and Zollner enter into a strategic partnership for electronically controlled medtech systems from a single source Gerresheimer AG